- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
IntelliPharmaCeutics | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
INTELLIPHARMACEUTICS INTERNATIONAL INC.
INTELLIPHARMACEUTICS INTERNATIONAL INC. develops both new and generic controlled-released pharmaceutical products and licenses these developed products for commercialization
|
|
| Symbol: |
I |
| Exchange(s): |
Toronto Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Nov 30, 2008
12 Months
C$
|
Nov 30, 2007
12 Months
C$
|
Nov 30, 2006
12 Months
C$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
818
|
1,310
|
1,971
|
-35.10
|
|
Earnings before Interest & Tax ($000)
|
-16,074
|
-27,119
|
-52,611
|
N/A
|
|
Profit/Loss ($000)
|
-16,074
|
-28,777
|
-66,360
|
N/A
|
|
Earnings per Share
|
-0.72
|
-1.46
|
-7.10
|
N/A
|
|
Total Assets ($000)
|
9,342
|
28,050
|
41,770
|
-53.81
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
-102.20
|
-120.06
|
-233.31
|
|
|
Employees
|
6
|
100
|
120
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Aug 31, 2009, C$
|
12 Months ended
Aug 31, 2008, C$
|
%Change
|
|
Total Revenue ($000)
|
235
|
1,157
|
-79.69
|
|
Profit/Loss ($000)
|
-5,244
|
-21,382
|
75.48
|
|
Earnings per Share
|
-0.23
|
-0.94
|
75.53
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
22,623,195
|
22,391,386
|
|
|
|
|
|
COMPANY INFORMATION
|
|
Report on Business Magazine Top 1000 Ranking
|
| Profit: 0 |
Revenue: 0 |
Assets: 0 |
|
|
|
| Key Personnel |
| CEO: Chris Waddick, President & C.E.O. |
| CFO: Graham Neil, V.P. Finance & C.F.O. |
| |
| Contact Information |
| Address: |
30 Worcester Road,
Toronto,
ON,
M9W 5X2 |
Phone: |
416-798-3001 |
| Fax: |
416-798-3007 |
| Web Address: |
www.intellipharmaceutics.com |
| E-Mail : |
iodidi@intellipharmaceutics.com |
| Investor Relations: |
Isa Odidi, 416-798-3001 |
| |
| Company Type: |
Public |
Company Status: |
Active |
| Auditors: |
Kpmg Llp |
| Transfer Agent: |
Cibc Mellon Trust Company Toronto |
| Incorporation:
| Ontario, Jan 13, 1980 |
| |
|
Securities:
|
IPCI-Q I-T
|
|
| |
|
|
| |
|
|
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
